Celgene Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Celgene prevailing Real Value cannot be determined due to lack of data. The current price of Celgene is $0.0. Our model approximates the value of Celgene from analyzing the firm fundamentals such as Return On Equity of 1.0E-4, profit margin of 0.30 %, and Current Valuation of 85.34 B as well as examining its technical indicators and probability of bankruptcy.
Celgene Total Value Analysis
Celgene is currently expected to have valuation of 85.34 B with market capitalization of 77.04 B, debt of 20.1 B, and cash on hands of 9.32 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Celgene fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
85.34 B | 77.04 B | 20.1 B | 9.32 B |
Celgene Investor Information
About 78.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.67. Celgene recorded earning per share (EPS) of 7.32. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 26th of June 2014. Based on the measurements of operating efficiency obtained from Celgene's historical financial statements, Celgene is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Celgene Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Celgene has an asset utilization ratio of 1476.57 percent. This implies that the Company is making $14.77 for each dollar of assets. An increasing asset utilization means that Celgene is more efficient with each dollar of assets it utilizes for everyday operations.Celgene Ownership Allocation
Celgene holds a total of 708.74 Million outstanding shares. The majority of Celgene outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Celgene to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Celgene. Please pay attention to any change in the institutional holdings of Celgene as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Celgene Profitability Analysis
The company reported the previous year's revenue of 16.35 B. Net Income was 5.27 B with profit before overhead, payroll, taxes, and interest of 14.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Celgene's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Celgene and how it compares across the competition.
Celgene Growth Indicators
Investing in growth stocks can be very risky. If the company such as Celgene does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Shares Percent Shares Out | 1.82% | |
| Earnings Quarterly Growth | 56.30% | |
| Revenue Growth | 16.10% | |
| Forward Price Earnings | 8.72 | |
| Float Shares | 709.39M | |
| Shares Short Prior Month | 11.76M | |
| Earnings Growth | 54.70% |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Celgene Stock
If you are still planning to invest in Celgene check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celgene's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |